Cart
sales@molnova.com
Esculentoside H
CAS No. 66656-92-6
Esculentoside H( —— )
Catalog No. M18970 CAS No. 66656-92-6
Phytolaccaceae has anti-tumor activity, the mechanism may be related to the capacity of Esculentoside H for TNF release.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 113 | In Stock |
|
| 10MG | 186 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEsculentoside H
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhytolaccaceae has anti-tumor activity, the mechanism may be related to the capacity of Esculentoside H for TNF release.
-
DescriptionPhytolaccaceae has anti-tumor activity, the mechanism may be related to the capacity of Esculentoside H for TNF release.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorTNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66656-92-6
-
Formula Weight989.1
-
Molecular FormulaC48H76O21
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (101.10 mM)
-
SMILESO=C(OC)[C@@]6(C)CC[C@@]7(CC[C@]5(C)C(=CC[C@H]4[C@@]5(C)CC[C@H]3[C@](C)(CO)[C@@H](O[C@@H]2OC[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]2O)[C@@H](O)C[C@@]34C)[C@@H]7C6)C(=O)O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hu ZL, Zhang JP, et al.Effect of esculentoside H on release of tumor necrosis factor from mouse peritoneal macrophages.Zhongguo Yao Li Xue Bao. 1993 Nov;14(6):550-2.
molnova catalog
related products
-
Ganitumab
Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R). Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 and IGF2 in mice, making it useful for cancer research.
-
KW-2450 free base
KW-2450 free base is an orally bioavailable inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) tyrosine kinases with potential antineoplastic activity.
-
Linsitinib
Linsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively.
